Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/REGULUS-THERAPEUTICS-INC-46475580/news/Regulus-Therapeutics-gibt-den-Erhalt-der-FDA-Orphan-Drug-Designation-fur-RGLS8429-zur-Behandlung-de-40785862/?utm_source=whatsapp&utm_medium=social&utm_campaign=share